Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Here's a look at Tilray's recent performance compared with its largest competitors.

How Did Tilray Stack Up to the Competition?

Pot stocks were more concerned with supporting inflated valuations than meeting grow expectations, according to this prominent cannabis CEO.

Marijuana Companies Lied to You, Major Pot CEO Alleges

After a revenue beat Tilray Inc saw its stock jump 5 percent for the day. However, that optimism has faded rather quickly, and TLRY stock has not been able to capitalize on that momentum.

Don’t Let the Great Q1 Numbers Fool You into Buying Tilray Stock

Skeptics have lost fortunes trying to short Amazon and Netflix. They shouldn't make the same mistake with cannabis stocks like TLRY stock.

The Bullish Thesis for Tilray Stock Is Still Alive and Well

Marijuana stock upgrades have been few and far between, especially for this popular player.

Say What? Someone Actually Upgraded This Pot Stock?

Cannabis company Tilray's latest financial report includes plenty of pros and cons.

Marijuana Stocks: 5 Facts About Tilray's Quarterly Performance

But there are also two reasons that it might not.

4 Reasons Tilray Stock Could Soar This Year

Sales growth aside, this was another subpar quarter for the sixth-largest pot stock.

The 5 Scariest Numbers in Tilray's First-Quarter Report

Tilray reported it's ramping sales rapidly.

Tilray grows production, beats pot sales forecasts

Tilray Inc. reported Tuesday with first-quarter results that were highlighted by a 195-percent jump in revenue year-over-year — and show the long-term opportunity within the cannabis space, CEO Brendan Kennedy told CNBC following the earnings release.

Tilray CEO On Cannabis Company's Q1:  'Our Objective Is To Invest For The Long-Term'

Aurora Cannabis

Markets remained volatile as trade talk swirled.

Stock Market News: Tilray, Aurora Cannabis Put Pot in the Spotlight

Is Tilray's strong first-quarter report a good reason to buy this flagging pot stock?

Is Tilray Finally a Buy?

When cannabis company Tilray Inc. (NASDAQ: TLRY) reported its most recent quarterly results after the markets closed on Tuesday, it said that it had a net loss of $0.27 per share on $23.0 million in revenue.

Why Tilray Earnings Are Still Hazy for Investors

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q1 2019 Results - Earnings Call Transcript

Tilray reported its quarterly earnings results late today, bringing in a loss that was wider than expected, yet a revenue beat lifted TLRY.
The post Tilray Earnings: TLRY Stock Surges on Wide Q1 Loss, Revenue Beat appeared first on InvestorPlace.

Tilray Earnings: TLRY Stock Surges on Wide Q1 Loss, Revenue Beat

The Canadian marijuana producer's revenue nearly tripled year over year in Q1. Here's why.

3 Things That Fueled Tilray's Tremendous Revenue Jump in Q1

Canadian cannabis company Tilray Inc (NASDAQ: TLRY) reported first-quarter financial results after the close Tuesday.

Tilray Trades Higher On Q1 Report; Revenue Rises 195% Year-Over-Year

CannTrust reported a loss and 115% revenue growth early Tuesday. Aurora Cannabis and Tilray are expected to report losses and big sales gains after the close.

Marijuana Stocks: CannTrust Earnings Shows Big Revenue Gain; Aurora Cannabis, Tilray Due Late

Tilray stock is looking attractive after a brutal selloff. Time to buy into the cannabis growth story at a reasonable price.

Tilray Stock Is Heading Higher With a $70 Price Target

Aphria

Canopy Growth

Cronos Group

CannTrust Holdings

HEXO Corp

Some Canadian marijuana growers are deceivingly cheap, while others appear downright avoidable.

Which Pot Stocks Are the Cheapest Relative to 2020 Sales?

Tilray has plunged from its parabolic spike peak but is still up about 200% since its IPO. Despite the correction to below $50, the stock doesn't look especially compelling.

Tilray Is No Bargain Despite Dropping $250

Village Farms International

Don't just look at year-to-date performance in choosing between these two Canadian marijuana stocks.

Better Marijuana Stock: Tilray vs. Village Farms

The current cannabis regulatory environment is tough because it is a patchwork. Meanwhile, the federal government looms in the background.

Cannabis Craze Faces Regulatory Changes, Including A Key Bill

Scotts Miracle-Gro

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Get Higher on Cannabis Stocks

This $32.6 million investment is a real head-scratcher.

News for Tilray Brands Stock (TLRY)